← back to search

Yangxue Li

Jilin University · CN
Area of research
Materials Chemistry · Inorganic Chemistry
Research interest
Research focused on Hyperlipidemia and Membrane, with related work in Ferulic acid, Chemical engineering, Pharmacology. Notable publications include 'Acid-resistant supramolecular nanofibrous hydrogel membrane with core-shell structure for highly efficient oil/water separation', 'The Protective Effect of MicroRNA-320 on Left Ventricular Remodeling after Myocardial Ischemia-Reperfusion Injury in the Rat Model', and 'Chelation-directed interface engineering of in-place self-cleaning membranes'.
h-index
citations
302
works
13
NIH funding
primary concept
email

Recent publications

Integrated serum pharmacochemistry, pharmacokinetics, and network analysis to explore active components of BuShao Tiaozhi Capsule on hyperlipidemia
Frontiers in Pharmacology 2025cited by 4position: middledoi
Mechanisms of Microctis Folium in Hyperlipidemia: Integrating Serum Pharmacochemistry, Network Pharmacology, and Transcriptomics
Drug Design Development and Therapy 2025cited by 2position: middledoi
Chelation-directed interface engineering of in-place self-cleaning membranes
Proceedings of the National Academy of Sciences 2024cited by 45position: middledoi
ESL attenuates BLM-induced IPF in mice: Dual mediation of the TLR4/NF-κB and TGF-β1/PI3K/Akt/FOXO3a pathways
Phytomedicine 2024cited by 16position: middledoi
Metabolomics and network pharmacology reveal partial insights into the hypolipidemic mechanisms of ferulic acid in a dyslipidemia mouse model
Frontiers in Pharmacology 2024cited by 3position: middledoi
Anti-liver tumor ingredient exploration and validation of Elephantopus tomentosus Linn. by combining in silico and in vitro experiments
Scientific Reports 2024cited by 3position: middledoi
Acid-resistant supramolecular nanofibrous hydrogel membrane with core-shell structure for highly efficient oil/water separation
Journal of Membrane Science 2023cited by 86position: middledoi
Metabolomics analysis delineates the therapeutic effects of Yinlan Tiaozhi capsule on triton WR-1339 -induced hyperlipidemia in mice
Frontiers in Pharmacology 2023cited by 12position: middledoi
Deciphering the mechanisms of Yinlan Tiaozhi capsule in treating hyperlipidemia by combining network pharmacology, molecular docking and experimental verification
Scientific Reports 2023cited by 11position: middledoi
[Prediction and analysis of Q-markers of Elephantopus scaber based on its UPLC fingerprint, content determination of components, and in vitro a nti-tumor activity].
PubMed 2023cited by 2position: middledoi
Network pharmacology analysis and experimental validation to explore the mechanism of Bushao Tiaozhi capsule (BSTZC) on hyperlipidemia
Scientific Reports 2022cited by 19position: middledoi
Network Pharmacology and Molecular Docking‐Based Prediction of the Mechanism of Qianghuo Shengshi Decoction against Rheumatoid Arthritis
BioMed Research International 2021cited by 38position: middledoi
The Protective Effect of MicroRNA-320 on Left Ventricular Remodeling after Myocardial Ischemia-Reperfusion Injury in the Rat Model
International Journal of Molecular Sciences 2014cited by 61position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Guanlin Xiao · Guangzhou University of Chinese Medicine9 papers (2021–2025)Zhihao Zeng · Guangzhou University of Chinese Medicine8 papers (2021–2025)Xiaoli Bi · Guangzhou University of Chinese Medicine8 papers (2022–2025)Sumei Li · First People's Hospital of Nanning7 papers (2021–2025)Canchao Jia · Guangzhou University of Chinese Medicine6 papers (2023–2025)Dezheng Jia · Guangzhou University of Chinese Medicine5 papers (2023–2025)Yanchang Liu · Guangzhou University of Chinese Medicine4 papers (2024–2025) · 3 papers (2022–2024)Zhao Chen · University of Arizona3 papers (2022–2023)Ruiyin Tang · Guangzhou University of Chinese Medicine3 papers (2024–2025) · 3 papers (2022–2023)Dake Cai · Guangzhou University of Chinese Medicine3 papers (2023–2024)Dongmei Li · University of Rochester Medical Center2 papers (2024–2025)Lingjie Li · Guangdong Provincial People's Hospital2 papers (2024–2024)Linlin Yan · Wenzhou Medical University2 papers (2023–2024)Xu Aili · Guangzhou University of Chinese Medicine2 papers (2023–2024)Canhui Xie · Guangzhou University of Chinese Medicine2 papers (2024–2024)Guangying Wu · Guangzhou University of Chinese Medicine2 papers (2024–2025)Lu Shao · University of California, Riverside2 papers (2023–2024)Xiaobin Yang · Harbin Institute of Technology2 papers (2023–2024)